These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 1548088

  • 81. Development of a vaccine of cross-linked heat-stable and heat-labile enterotoxins that protects against Escherichia coli producing either enterotoxin.
    Klipstein FA, Engert RF, Clements JD.
    Infect Immun; 1982 Aug; 37(2):550-7. PubMed ID: 6749682
    [Abstract] [Full Text] [Related]

  • 82. Development of two novel nontoxic mutants of Escherichia coli heat-labile enterotoxin.
    Park EJ, Chang JH, Kim JS, Chung SI, Yum JS.
    Exp Mol Med; 1999 Jun 30; 31(2):101-7. PubMed ID: 10410310
    [Abstract] [Full Text] [Related]

  • 83. Escherichia coli heat-labile enterotoxin. Ganglioside specificity and ADP-ribosyltransferase activity.
    Moss J, Osborne JC, Fishman PH, Nakaya S, Robertson DC.
    J Biol Chem; 1981 Dec 25; 256(24):12861-5. PubMed ID: 6273411
    [No Abstract] [Full Text] [Related]

  • 84. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
    Verweij WR, de Haan L, Holtrop M, Agsteribbe E, Brands R, van Scharrenburg GJ, Wilschut J.
    Vaccine; 1998 Dec 25; 16(20):2069-76. PubMed ID: 9796066
    [Abstract] [Full Text] [Related]

  • 85. A single amino acid substitution in the A subunit of Escherichia coli enterotoxin results in a loss of its toxic activity.
    Tsuji T, Inoue T, Miyama A, Okamoto K, Honda T, Miwatani T.
    J Biol Chem; 1990 Dec 25; 265(36):22520-5. PubMed ID: 2266142
    [Abstract] [Full Text] [Related]

  • 86. Inhibition of T-cell response by Escherichia coli heat-labile enterotoxin-treated epithelial cells.
    Lopes LM, Maroof A, Dougan G, Chain BM.
    Infect Immun; 2000 Dec 25; 68(12):6891-5. PubMed ID: 11083810
    [Abstract] [Full Text] [Related]

  • 87.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 88. Significance of heat-stable and heat-labile enterotoxins in porcine colibacillosis in an additive model for pathogenicity studies.
    Zhang W, Berberov EM, Freeling J, He D, Moxley RA, Francis DH.
    Infect Immun; 2006 Jun 25; 74(6):3107-14. PubMed ID: 16714538
    [Abstract] [Full Text] [Related]

  • 89.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 90. Differential binding of Escherichia coli enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells.
    Arce S, Nawar HF, Russell MW, Connell TD.
    Infect Immun; 2005 May 25; 73(5):2718-27. PubMed ID: 15845474
    [Abstract] [Full Text] [Related]

  • 91.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 92. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.
    de Haan L, Holtrop M, Verweij WR, Agsteribbe E, Wilschut J.
    Vaccine; 1996 Mar 25; 14(4):260-6. PubMed ID: 8744549
    [Abstract] [Full Text] [Related]

  • 93. Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.
    Hagiwar Y, Tsuji T, Iwasaki T, Kadowaki S, Asanuma H, Chen Z, Komase K, Suzuki Y, Aizawa C, Kurata T, Tamura S.
    Vaccine; 2001 Feb 28; 19(15-16):2071-9. PubMed ID: 11228379
    [Abstract] [Full Text] [Related]

  • 94. Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I).
    Nawar HF, Berenson CS, Hajishengallis G, Takematsu H, Mandell L, Clare RL, Connell TD.
    Clin Vaccine Immunol; 2010 Jun 28; 17(6):969-78. PubMed ID: 20392887
    [Abstract] [Full Text] [Related]

  • 95. Recombinant enterotoxins as vaccines against Escherichia coli-mediated diarrhoea.
    Aitken R, Hirst TR.
    Vaccine; 1993 Jun 28; 11(2):227-33. PubMed ID: 8438620
    [Abstract] [Full Text] [Related]

  • 96. Role of a potential endoplasmic reticulum retention sequence (RDEL) and the Golgi complex in the cytotonic activity of Escherichia coli heat-labile enterotoxin.
    Cieplak W, Messer RJ, Konkel ME, Grant CC.
    Mol Microbiol; 1995 May 28; 16(4):789-800. PubMed ID: 7476173
    [Abstract] [Full Text] [Related]

  • 97. Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid.
    Holmgren J.
    Infect Immun; 1973 Dec 28; 8(6):851-9. PubMed ID: 4206342
    [Abstract] [Full Text] [Related]

  • 98. Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin.
    Savarino SJ, Fasano A, Watson J, Martin BM, Levine MM, Guandalini S, Guerry P.
    Proc Natl Acad Sci U S A; 1993 Apr 01; 90(7):3093-7. PubMed ID: 8385356
    [Abstract] [Full Text] [Related]

  • 99.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 100. Escherichia coli heat-labile enterotoxin genes are flanked by repeated deoxyribonucleic acid sequences.
    Yamamoto T, Yokota T.
    J Bacteriol; 1981 Feb 01; 145(2):850-60. PubMed ID: 6257652
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.